A Prospective Research Investigation of Ischemia Using MCG

Recruiting now

Conditions studied: Acute Coronary Syndrome

In brief

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Key facts

Study ID

NCT06481943

Run by

SB Technology, Inc.

People needed

150

Starts

2024-07-11

Expected to finish

2026-04-01

Last updated by the study team

2025-10-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction
• Ability for participant to comply with study requirements
• Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities
• Written informed consent

You may not qualify if…

• Present STEMI
• Pregnant or breastfeeding
• Having an active atrial fibrillation episode as seen on most current 12-lead ECG
• Active thoracic metal implant
• Poor access to follow-up

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States (enrolling)
• Mount Sinai Hospital — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.